"Arthritis, Psoriatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
| Descriptor ID |
D015535
|
| MeSH Number(s) |
C05.116.900.853.625.800.424 C05.550.114.145 C05.550.114.865.800.424 C17.800.859.675.175
|
| Concept/Terms |
Arthritis, Psoriatic- Arthritis, Psoriatic
- Psoriasis, Arthritic
- Arthritic Psoriasis
- Psoriatic Arthritis
- Psoriasis Arthropathica
- Psoriatic Arthropathy
- Arthropathies, Psoriatic
- Arthropathy, Psoriatic
- Psoriatic Arthropathies
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Psoriatic".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Psoriatic".
This graph shows the total number of publications written about "Arthritis, Psoriatic" by people in this website by year, and whether "Arthritis, Psoriatic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Psoriatic" by people in Profiles.
-
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series. RMD Open. 2024 Aug 30; 10(3).
-
ROR?t inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating ?d-T cells. Rheumatology (Oxford). 2023 09 01; 62(9):3169-3178.
-
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations. J Rheumatol. 2023 03; 50(3):438-450.
-
Treatment Persistence and Adherence Among Patients With Psoriatic Arthritis Who Initiated Targeted Immune Modulators in the US: A Retrospective Cohort Study. Adv Ther. 2021 05; 38(5):2353-2364.
-
Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies. Curr Med Res Opin. 2020 07; 36(7):1245-1252.
-
A20 restricts inflammation via ubiquitin binding. Nat Immunol. 2020 04; 21(4):362-364.
-
Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis. J Manag Care Spec Pharm. 2019 Nov; 25(11):1218-1228.
-
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ Open. 2019 07 09; 9(7):e028517.
-
Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheumatol. 2019 06; 71(6):941-951.
-
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1028-1035.